News Focus
News Focus
Followers 23
Posts 2847
Boards Moderated 0
Alias Born 03/22/2021

Re: TheFollower post# 776801

Saturday, 07/19/2025 10:54:38 AM

Saturday, July 19, 2025 10:54:38 AM

Post# of 823731
"If DCVax-L is approved after July 23, it benefits from this framework directly. If approved before, any later switch to Flaskworks would be considered a major variation, requiring extensive revalidation."

I thought flaskworks was allready approved and part of the submission.
I also thought variations had to be submitted during approval process.
Why would a better automated system delay approval of a treatment? Better systems are developed all the time and stand on their own for validation.

"What are the implications of SI 2025 No. 87?
The implications of SI 2025 No. 87, which takes effect at the UK’s MHRA on July 23, 2025, are quite significant—especially for cutting-edge therapies like DCVax-L from Northwest Biotherapeutics."


This is why I hate AI. What will tomorrow be like? Answer- tomorrow will have weather and last 24 hrs.

If approval happens this week or the next, I'll be happy as a clam. But I don't believe the delay of over 1 1/2 years was due to waiting for this new regulation. It seems like investors are trying to find a timeline on which to look forward to and are creating narratives to justify this timeline. JMO
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News